{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:19:05Z","timestamp":1788466745857,"version":"build-2803163510"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11220657"],"award-info":[{"award-number":["11220657"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1201635"],"award-info":[{"award-number":["1201635"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02147-9","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T01:59:57Z","timestamp":1764899997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6759-6306","authenticated-orcid":false,"given":"Areli","family":"C\u00e1rdenas-Oyarzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Armijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00eda","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-3827","authenticated-orcid":false,"given":"Edgardo","family":"Rojas-Mancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2519-7570","authenticated-orcid":false,"given":"Pamela","family":"Ehrenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"2147_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fmed.2019.00136","volume":"6","author":"F Alhenc-Gelas","year":"2019","unstructured":"Alhenc-Gelas F, Bouby N, Girolami J-P. Kallikrein\/K1, Kinins, and ACE\/Kininase II in homeostasis and in disease insight from human and experimental genetic Studies, therapeutic implication. Front Med. 2019;6:136. https:\/\/doi.org\/10.3389\/fmed.2019.00136.","journal-title":"Front Med"},{"key":"2147_CR2","doi-asserted-by":"publisher","first-page":"106305","DOI":"10.1016\/j.intimp.2020.106305","volume":"82","author":"F Marceau","year":"2020","unstructured":"Marceau F, Bachelard H, Bouthillier J, Fortin J-P, Morissette G, Bawolak M-T, et al. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int Immunopharmacol. 2020;82:106305. https:\/\/doi.org\/10.1016\/j.intimp.2020.106305.","journal-title":"Int Immunopharmacol"},{"key":"2147_CR3","doi-asserted-by":"publisher","unstructured":"Leeb-Lundberg LMF. 3 Kinin receptor signaling and regulation. In: Bader M, editor. Kinins [Internet]. DE GRUYTER; 2011 [cited 2025 May 27]. pp. 33\u201350. https:\/\/doi.org\/10.1515\/9783110252354.33","DOI":"10.1515\/9783110252354.33"},{"key":"2147_CR4","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.mbplus.2019.100019","volume":"6\u20137","author":"P Nauroy","year":"2020","unstructured":"Nauroy P, Nystr\u00f6m A, Kallikreins. Essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease. Matrix Biol Plus. 2020;6\u20137:100019. https:\/\/doi.org\/10.1016\/j.mbplus.2019.100019.","journal-title":"Matrix Biol Plus"},{"key":"2147_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fncel.2020.00166","volume":"14","author":"C Mella","year":"2020","unstructured":"Mella C, Figueroa CD, Otth C, Ehrenfeld P. Involvement of Kallikrein-Related peptidases in nervous system disorders. Front Cell Neurosci. 2020;14:166. https:\/\/doi.org\/10.3389\/fncel.2020.00166.","journal-title":"Front Cell Neurosci"},{"key":"2147_CR6","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1074\/mcp.M115.057695","volume":"15","author":"TD Karakosta","year":"2016","unstructured":"Karakosta TD, Soosaipillai A, Diamandis EP, Batruch I, Drabovich AP. Quantification of human Kallikrein-Related peptidases in biological fluids by multiplatform targeted mass spectrometry assays. Mol Cell Proteom. 2016;15:2863\u201376. https:\/\/doi.org\/10.1074\/mcp.M115.057695.","journal-title":"Mol Cell Proteom"},{"key":"2147_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI23669","volume":"115","author":"M Azizi","year":"2005","unstructured":"Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N, et al. Arterial and renal consequences of partial genetic deficiency in tissue Kallikrein activity in humans. J Clin Invest. 2005;115:780\u20137. https:\/\/doi.org\/10.1172\/JCI23669.","journal-title":"J Clin Invest"},{"key":"2147_CR8","doi-asserted-by":"publisher","unstructured":"Ji M, Ran X, Zuo H, Zhang Q. Novel insights into the Kallikrein\u2013Kinin system in fulminant myocarditis: physiological basis and potential therapeutic advances. J Inflamm Res 2024;Volume 17:7347\u201360. https:\/\/doi.org\/10.2147\/JIR.S488237","DOI":"10.2147\/JIR.S488237"},{"key":"2147_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12079-021-00652-0","volume":"16","author":"DAB Rex","year":"2022","unstructured":"Rex DAB, Deepak K, Vaid N, Dagamajalu S, Kandasamy RK, Flo TH, et al. A modular map of Bradykinin-mediated inflammatory signaling network. J Cell Commun Signal. 2022;16:301\u201310. https:\/\/doi.org\/10.1007\/s12079-021-00652-0.","journal-title":"J Cell Commun Signal"},{"key":"2147_CR10","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.4049\/jimmunol.179.7.4849","volume":"179","author":"J Duchene","year":"2007","unstructured":"Duchene J, Lecomte F, Ahmed S, Cayla C, Pesquero J, Bader M, et al. A novel inflammatory pathway involved in leukocyte recruitment: role for the Kinin B1 receptor and the chemokine CXCL5. J Immunol Baltim Md 1950. 2007;179:4849\u201356. https:\/\/doi.org\/10.4049\/jimmunol.179.7.4849.","journal-title":"J Immunol Baltim Md 1950"},{"key":"2147_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bone.2008.02.003","volume":"43","author":"AB Brechter","year":"2008","unstructured":"Brechter AB, Persson E, Lundgren I, Lerner UH. Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases. Bone. 2008;43:72\u201383. https:\/\/doi.org\/10.1016\/j.bone.2008.02.003.","journal-title":"Bone"},{"key":"2147_CR12","doi-asserted-by":"publisher","first-page":"1188816","DOI":"10.3389\/fphys.2023.1188816","volume":"14","author":"G Motta","year":"2023","unstructured":"Motta G, Juliano L, Chagas JR. Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond. Front Physiol. 2023;14:1188816. https:\/\/doi.org\/10.3389\/fphys.2023.1188816.","journal-title":"Front Physiol"},{"key":"2147_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70170","author":"L Sasiadek","year":"2025","unstructured":"Sasiadek L, Bielecka E, Falkowski K, Kulczycka M, Bereta G, Maksylewicz A, et al. Human tissue Kallikrein 14 induces the expression of IL -6, IL \u20108, and CXCL1 in skin fibroblasts through protease\u2010activated receptor 1 signaling. FEBS J. 2025. https:\/\/doi.org\/10.1111\/febs.70170. febs.70170.","journal-title":"FEBS J"},{"key":"2147_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20082242","volume":"206","author":"A Briot","year":"2009","unstructured":"Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med. 2009;206:1135\u201347. https:\/\/doi.org\/10.1084\/jem.20082242.","journal-title":"J Exp Med"},{"key":"2147_CR15","doi-asserted-by":"publisher","first-page":"156239","DOI":"10.1016\/j.metabol.2025.156239","volume":"168","author":"A Ribas-Latre","year":"2025","unstructured":"Ribas-Latre A, Hoffmann A, Gebhardt C, Weiner J, Arndt L, Raulien N, et al. The Serine protease KLK7 promotes immune cell infiltration in visceral adipose tissue in obesity. Metabolism. 2025;168:156239. https:\/\/doi.org\/10.1016\/j.metabol.2025.156239.","journal-title":"Metabolism"},{"key":"2147_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-031-63657-8_4","volume-title":"Obes lipotoxicity [Internet]","author":"A Engin","year":"2024","unstructured":"Engin A. Lipid Storage, Lipolysis, and lipotoxicity in obesity. In: Engin AB, Engin A, editors. Obes lipotoxicity [Internet]. Cham: Springer International Publishing; 2024. pp. 97\u2013129. [cited 2025 May 27]. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_4."},{"key":"2147_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/978-3-031-63657-8_16","volume-title":"Obes lipotoxicity [Internet]","author":"A Engin","year":"2024","unstructured":"Engin A. The mechanism of leptin resistance in obesity and therapeutic perspective. In: Engin AB, Engin A, editors. Obes lipotoxicity [Internet]. Cham: Springer International Publishing; 2024. pp. 463\u201387. [cited 2025 May 27]. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_16."},{"key":"2147_CR18","doi-asserted-by":"publisher","first-page":"2200234","DOI":"10.1002\/adbi.202200234","volume":"7","author":"J Yu","year":"2023","unstructured":"Yu J, Qiu J, Zhang Z, Cui X, Guo W, Sheng M, et al. Redox biology in adipose tissue physiology and obesity. Adv Biol. 2023;7:2200234. https:\/\/doi.org\/10.1002\/adbi.202200234.","journal-title":"Adv Biol"},{"key":"2147_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00018-022-04169-6","volume":"79","author":"M Audano","year":"2022","unstructured":"Audano M, Pedretti S, Caruso D, Crestani M, De Fabiani E, Mitro N. Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview. Cell Mol Life Sci. 2022;79:139. https:\/\/doi.org\/10.1007\/s00018-022-04169-6.","journal-title":"Cell Mol Life Sci"},{"key":"2147_CR20","doi-asserted-by":"publisher","first-page":"117073","DOI":"10.1016\/j.biopha.2024.117073","volume":"177","author":"H-Y Kim","year":"2024","unstructured":"Kim H-Y, Jang H-J, Muthamil S, Shin UC, Lyu J-H, Kim S-W, et al. Novel insights into regulators and functional modulators of adipogenesis. Biomed Pharmacother. 2024;177:117073. https:\/\/doi.org\/10.1016\/j.biopha.2024.117073.","journal-title":"Biomed Pharmacother"},{"key":"2147_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7570\/jomes24013","volume":"33","author":"M Bl\u00fcher","year":"2024","unstructured":"Bl\u00fcher M. Understanding adipose tissue dysfunction. J Obes Metab Syndr. 2024;33:275\u201388. https:\/\/doi.org\/10.7570\/jomes24013.","journal-title":"J Obes Metab Syndr"},{"key":"2147_CR22","doi-asserted-by":"publisher","first-page":"116324","DOI":"10.1016\/j.bcp.2024.116324","volume":"225","author":"N Dahdah","year":"2024","unstructured":"Dahdah N, Tercero-Alc\u00e1zar C, Malag\u00f3n MM, Garcia-Roves PM, Guzm\u00e1n-Ruiz R. Interrelation of adipose tissue macrophages and fibrosis in obesity. Biochem Pharmacol. 2024;225:116324. https:\/\/doi.org\/10.1016\/j.bcp.2024.116324.","journal-title":"Biochem Pharmacol"},{"key":"2147_CR23","doi-asserted-by":"publisher","first-page":"e16159","DOI":"10.1111\/liv.16159","volume":"45","author":"J Bilson","year":"2025","unstructured":"Bilson J, Hydes TJ, McDonnell D, Buchanan RM, Scorletti E, Mantovani A, et al. Impact of metabolic syndrome traits on kidney disease risk in individuals with MASLD: A UK biobank study. Liver Int Off J Int Assoc Study Liver. 2025;45:e16159. https:\/\/doi.org\/10.1111\/liv.16159.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"2147_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13956","author":"L Turner","year":"2025","unstructured":"Turner L, Wanasinghe AI, Brunori P, Santosa S. Is adipose tissue inflammation the culprit of Obesity-Associated comorbidities? Obes Rev. 2025. https:\/\/doi.org\/10.1111\/obr.13956. e13956.","journal-title":"Obes Rev"},{"key":"2147_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1517\/14728222.2013.827664","volume":"17","author":"N Blaes","year":"2013","unstructured":"Blaes N, Girolami J-P. Targeting the Janus face of the B2-bradykinin receptor. Expert Opin Ther Targets. 2013;17:1145\u201366. https:\/\/doi.org\/10.1517\/14728222.2013.827664.","journal-title":"Expert Opin Ther Targets"},{"key":"2147_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1139\/cjpp-2016-0063","volume":"94","author":"S Talbot","year":"2016","unstructured":"Talbot S, Dias JP, El Midaoui A, Couture R. Beneficial effects of Kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats. Can J Physiol Pharmacol. 2016;94:752\u20137. https:\/\/doi.org\/10.1139\/cjpp-2016-0063.","journal-title":"Can J Physiol Pharmacol"},{"key":"2147_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/db07-1508","volume":"57","author":"MA Mori","year":"2008","unstructured":"Mori MA, Ara\u00fajo RC, Reis FCG, Sgai DG, Fonseca RG, Barros CC, et al. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes. 2008;57:1491\u2013500. https:\/\/doi.org\/10.2337\/db07-1508.","journal-title":"Diabetes"},{"key":"2147_CR28","doi-asserted-by":"publisher","unstructured":"Mori MA, Sales VM, Motta FL, Fonseca RG, Alenina N, Guadagnini D et al. Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity. Ho PL, editor. PLoS ONE. 2012;7:e44782. https:\/\/doi.org\/10.1371\/journal.pone.0044782","DOI":"10.1371\/journal.pone.0044782"},{"key":"2147_CR29","doi-asserted-by":"publisher","first-page":"120007","DOI":"10.1016\/j.lfs.2021.120007","volume":"294","author":"LC Freitas-Lima","year":"2022","unstructured":"Freitas-Lima LC, Budu A, Estrela GR, Alves-Silva T, Perilh\u00e3o MS, Arruda AC, et al. Metabolic fasting stress is ameliorated in Kinin B1 receptor-deficient mice. Life Sci. 2022;294:120007. https:\/\/doi.org\/10.1016\/j.lfs.2021.120007.","journal-title":"Life Sci"},{"key":"2147_CR30","doi-asserted-by":"publisher","first-page":"e40573","DOI":"10.1371\/journal.pone.0040573","volume":"7","author":"CC Barros","year":"2012","unstructured":"Barros CC, Haro A, Russo FJVP, Schadock I, Almeida SS, Ribeiro RA et al. NOS C\u00e2mara editor 2012 Altered glucose homeostasis and hepatic function in obese mice deficient for both Kinin receptor genes. PLoS ONE 7 e40573 https:\/\/doi.org\/10.1371\/journal.pone.0040573.","journal-title":"PLoS ONE"},{"key":"2147_CR31","doi-asserted-by":"publisher","first-page":"e0134844","DOI":"10.1371\/journal.pone.0134844","volume":"10","author":"FCG Reis","year":"2015","unstructured":"Reis FCG, Haro AS, Bacurau AVN, Hirabara SM, Wasinski F, Ormanji MS et al. JA Chowen editor 2015 Deletion of Kinin B2 receptor alters muscle metabolism and exercise performance. PLoS ONE 10 e0134844 https:\/\/doi.org\/10.1371\/journal.pone.0134844.","journal-title":"PLoS ONE"},{"key":"2147_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2337\/diabetes.47.4.550","volume":"47","author":"K Kishi","year":"1998","unstructured":"Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, Hayashi H, et al. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes. 1998;47:550\u20138. https:\/\/doi.org\/10.2337\/diabetes.47.4.550.","journal-title":"Diabetes"},{"key":"2147_CR33","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.2337\/db05-1538","volume":"55","author":"KM Beard","year":"2006","unstructured":"Beard KM, Lu H, Ho K, Fantus IG. Bradykinin augments Insulin-Stimulated glucose transport in rat adipocytes via endothelial nitric oxide Synthase\u2013Mediated Inhibition of Jun NH2-Terminal kinase. Diabetes. 2006;55:2678\u201387. https:\/\/doi.org\/10.2337\/db05-1538.","journal-title":"Diabetes"},{"key":"2147_CR34","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1038\/s41467-023-38141-0","volume":"14","author":"F Xiao","year":"2023","unstructured":"Xiao F, Jiang H, Li Z, Jiang X, Chen S, Niu Y, et al. Reduced hepatic Bradykinin degradation accounts for cold-induced BAT thermogenesis and WAT Browning in male mice. Nat Commun. 2023;14:2523. https:\/\/doi.org\/10.1038\/s41467-023-38141-0.","journal-title":"Nat Commun"},{"key":"2147_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-024-05216-5","volume":"22","author":"P Wisniewski","year":"2024","unstructured":"Wisniewski P, Gangnus T, Burckhardt BB. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system. J Transl Med 2024 221 BioMed Cent. 2024;22:1\u201319. https:\/\/doi.org\/10.1186\/S12967-024-05216-5.","journal-title":"J Transl Med 2024 221 BioMed Cent"},{"key":"2147_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/cphy.c100053","volume":"1","author":"N-E Rhaleb","year":"2011","unstructured":"Rhaleb N-E, Yang X-P, Carretero OA. The kallikrein-kinin system as a regulator of cardiovascular and renal function. Compr Physiol. 2011;1:971\u201393. https:\/\/doi.org\/10.1002\/cphy.c100053.","journal-title":"Compr Physiol"},{"key":"2147_CR37","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_6389","author":"I Guevara-Lora","year":"2022","unstructured":"Guevara-Lora I, Sordyl M, Niewiarowska-Sendo A, Bras G, Korbut E, Goralska J, et al. The effect of Bradykinin on the pro-inflammatory response of human adipocytes. Acta Biochim Pol [Internet]. 2022. https:\/\/doi.org\/10.18388\/abp.2020_6389. [cited 2025 May 27].","journal-title":"Acta Biochim Pol [Internet]"},{"key":"2147_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbrc.2008.09.129","volume":"377","author":"Y-J Kim","year":"2008","unstructured":"Kim Y-J, Cho SY, Yun CH, Moon YS, Lee TR, Kim SH. Transcriptional activation of Cidec by PPAR\u03b32 in adipocyte. Biochem Biophys Res Commun. 2008;377:297\u2013302. https:\/\/doi.org\/10.1016\/j.bbrc.2008.09.129.","journal-title":"Biochem Biophys Res Commun"},{"key":"2147_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bcp.2013.06.005","volume":"86","author":"R-M Catalioto","year":"2013","unstructured":"Catalioto R-M, Valenti C, Liverani L, Giuliani S, Maggi CA. Characterization of a novel Proinflammatory effect mediated by BK and the Kinin B2 receptor in human preadipocytes. Biochem Pharmacol. 2013;86:508\u201320. https:\/\/doi.org\/10.1016\/j.bcp.2013.06.005.","journal-title":"Biochem Pharmacol"},{"key":"2147_CR40","doi-asserted-by":"publisher","first-page":"C63","DOI":"10.1152\/ajpcell.1984.246.1.C63","volume":"246","author":"RJ Schimmel","year":"1984","unstructured":"Schimmel RJ. Stimulation of cAMP accumulation and lipolysis in hamster adipocytes with forskolin. Am J Physiol-Cell Physiol. 1984;246:C63\u20138. https:\/\/doi.org\/10.1152\/ajpcell.1984.246.1.C63.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"2147_CR41","doi-asserted-by":"publisher","unstructured":"Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M. In situ assessment of the role of the \u03b21, \u03b22 - and \u03b23 \u2010adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol. 1996;117:907\u201313. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15279.x","DOI":"10.1111\/j.1476-5381.1996.tb15279.x"},{"key":"2147_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/febs.17157","volume":"292","author":"KA De Jong","year":"2025","unstructured":"De Jong KA, Siddig S, Pfeifer A, Nikolaev VO. The role of compartmentalized \u03b2-AR \/ cAMP signaling in the regulation of lipolysis in white and brown adipocytes. FEBS J. 2025;292:261\u201371. https:\/\/doi.org\/10.1111\/febs.17157.","journal-title":"FEBS J"},{"key":"2147_CR43","doi-asserted-by":"publisher","first-page":"8452","DOI":"10.1128\/MCB.21.24.8452-8460.2001","volume":"21","author":"S Hanke","year":"2001","unstructured":"Hanke S, N\u00fcrnberg B, Groll DH, Liebmann C. Cross talk between \u03b2-Adrenergic and Bradykinin B2 receptors results in cooperative regulation of Cyclic AMP accumulation and Mitogen-Activated protein kinase activity. Mol Cell Biol. 2001;21:8452\u201360. https:\/\/doi.org\/10.1128\/MCB.21.24.8452-8460.2001.","journal-title":"Mol Cell Biol"},{"key":"2147_CR44","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00011-024-01917-1","volume":"73","author":"J Branquinho","year":"2024","unstructured":"Branquinho J, Neves RL, Martin RP, Arata JG, Bittencourt CA, Ara\u00fajo RC, et al. Kinin B1 receptor deficiency promotes enhanced adipose tissue thermogenic response to \u03b23-adrenergic stimulation. Inflamm Res. 2024;73:1565\u201379. https:\/\/doi.org\/10.1007\/s00011-024-01917-1.","journal-title":"Inflamm Res"},{"key":"2147_CR45","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1021\/acs.jafc.0c00148","volume":"68","author":"W Zhang","year":"2020","unstructured":"Zhang W, An R, Li Q, Sun L, Lai X, Chen R, et al. Theaflavin TF3 relieves hepatocyte lipid deposition through activating an AMPK signaling pathway by targeting plasma Kallikrein. J Agric Food Chem. 2020;68:2673\u201383. https:\/\/doi.org\/10.1021\/acs.jafc.0c00148.","journal-title":"J Agric Food Chem"},{"key":"2147_CR46","doi-asserted-by":"publisher","unstructured":"Pollard AE. New concepts in the roles of AMPK in adipocyte stem cell biology. Salt I, Carling D, editors. Essays Biochem. 2024;68:349\u201361. https:\/\/doi.org\/10.1042\/EBC20240008","DOI":"10.1042\/EBC20240008"},{"key":"2147_CR47","doi-asserted-by":"publisher","first-page":"715111","DOI":"10.3389\/fphar.2021.715111","volume":"12","author":"IA Ahmed","year":"2021","unstructured":"Ahmed IA, Jaffa MA, Moussa M, Hatem D, El-Achkar GA, Al Sayegh R, et al. Plasma Kallikrein as a modulator of liver Injury\/Remodeling. Front Pharmacol. 2021;12:715111. https:\/\/doi.org\/10.3389\/fphar.2021.715111.","journal-title":"Front Pharmacol"},{"key":"2147_CR48","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijbs.8672","volume":"10","author":"S Mori","year":"2014","unstructured":"Mori S, Kiuchi S, Ouchi A, Hase T, Murase T. Characteristic expression of extracellular matrix in subcutaneous adipose tissue development and Adipogenesis; comparison with visceral adipose tissue. Int J Biol Sci. 2014;10:825\u201333. https:\/\/doi.org\/10.7150\/ijbs.8672.","journal-title":"Int J Biol Sci"},{"key":"2147_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-030-84763-0_11","volume-title":"Cell biochem mech Obes [Internet]","author":"FJ Ruiz-Ojeda","year":"2021","unstructured":"Ruiz-Ojeda FJ, Plaza-D\u00edaz J, Anguita-Ruiz A, M\u00e9ndez-Guti\u00e9rrez A, Aguilera CM. Adipose extracellular matrix remodeling in obesity and insulin resistance. In: Tappia PS, Ramjiawan B, Dhalla NS, editors. Cell biochem mech Obes [Internet]. Cham: Springer International Publishing; 2021. pp. 215\u201329. [cited 2025 Oct 11]. https:\/\/doi.org\/10.1007\/978-3-030-84763-0_11."},{"key":"2147_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/35060059","volume":"3","author":"S Selvarajan","year":"2001","unstructured":"Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol. 2001;3:267\u201375. https:\/\/doi.org\/10.1038\/35060059.","journal-title":"Nat Cell Biol"},{"key":"2147_CR51","doi-asserted-by":"publisher","first-page":"e020215","DOI":"10.1161\/JAHA.120.020215","volume":"10","author":"ES Lau","year":"2021","unstructured":"Lau ES, Paniagua SM, Zarbafian S, Hoffman U, Long MT, Hwang S, et al. Cardiovascular biomarkers of obesity and overlap with cardiometabolic dysfunction. J Am Heart Assoc. 2021;10:e020215. https:\/\/doi.org\/10.1161\/JAHA.120.020215.","journal-title":"J Am Heart Assoc"},{"key":"2147_CR52","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jmb.2008.12.021","volume":"386","author":"M Gioia","year":"2009","unstructured":"Gioia M, Monaco S, Van Den Steen PE, Sbardella D, Grasso G, Marini S, et al. The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. J Mol Biol. 2009;386:419\u201334. https:\/\/doi.org\/10.1016\/j.jmb.2008.12.021.","journal-title":"J Mol Biol"},{"key":"2147_CR53","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/biomedicines11051412","volume":"11","author":"I J\u00e4\u00e4skel\u00e4inen","year":"2023","unstructured":"J\u00e4\u00e4skel\u00e4inen I, Pet\u00e4ist\u00f6 T, Mirzarazi Dahagi E, Mahmoodi M, Pihlajaniemi T, Kaartinen MT, et al. Collagens Regulating Adipose Tissue Formation Funct Biomedicines. 2023;11:1412. https:\/\/doi.org\/10.3390\/biomedicines11051412.","journal-title":"Collagens Regulating Adipose Tissue Formation Funct Biomedicines"},{"key":"2147_CR54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00018-010-0263-4","volume":"67","author":"ECM Mariman","year":"2010","unstructured":"Mariman ECM, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci CMLS. 2010;67:1277\u201392. https:\/\/doi.org\/10.1007\/s00018-010-0263-4.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2147_CR55","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.3390\/ijms241310649","volume":"24","author":"S Moli\u00e8re","year":"2023","unstructured":"Moli\u00e8re S, Jaulin A, Tomasetto C-L, Dali-Youcef N. Roles of matrix metalloproteinases and their natural inhibitors in metabolism: insights into health and disease. Int J Mol Sci. 2023;24:10649. https:\/\/doi.org\/10.3390\/ijms241310649.","journal-title":"Int J Mol Sci"},{"key":"2147_CR56","doi-asserted-by":"publisher","unstructured":"Dias JP, Talbot S, S\u00e9n\u00e9cal J, Carayon P, Couture R. Kinin B1 Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications. Stadler K, editor. PLoS ONE. 2010;5:e12622. https:\/\/doi.org\/10.1371\/journal.pone.0012622","DOI":"10.1371\/journal.pone.0012622"},{"key":"2147_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/FJC.0b013e3182576277","volume":"60","author":"JP Dias","year":"2012","unstructured":"Dias JP, Couture R. Suppression of vascular inflammation by Kinin B1 receptor antagonism in a rat model of insulin resistance. J Cardiovasc Pharmacol. 2012;60:61\u20139. https:\/\/doi.org\/10.1097\/FJC.0b013e3182576277.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2147_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1515\/bchm3.1989.370.1.445","volume":"370","author":"K Rett","year":"1989","unstructured":"Rett K, Wicklmayr M, Fink E, Maerker E, Dietze G, Mehnert H. Local generation of Kinins in working skeletal muscle tissue in man. Biol Chem Hoppe Seyler. 1989;370:445\u201350. https:\/\/doi.org\/10.1515\/bchm3.1989.370.1.445.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"2147_CR59","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3389\/fphar.2020.01162","volume":"11","author":"MF Gregnani","year":"2020","unstructured":"Gregnani MF, Hungaro TG, Martins-Silva L, Bader M, Araujo RC. Bradykinin B2 receptor signaling increases glucose uptake and oxidation: evidence and open questions. Front Pharmacol. 2020;11:1162. https:\/\/doi.org\/10.3389\/fphar.2020.01162.","journal-title":"Front Pharmacol"},{"key":"2147_CR60","doi-asserted-by":"publisher","first-page":"E321","DOI":"10.1152\/ajpendo.00298.2016","volume":"313","author":"ME Frigolet","year":"2017","unstructured":"Frigolet ME, Thomas G, Beard K, Lu H, Liu L, Fantus IG. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and Inhibition of JNK. Am J Physiol-Endocrinol Metab. 2017;313:E321\u201334. https:\/\/doi.org\/10.1152\/ajpendo.00298.2016.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"2147_CR61","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00400672","volume":"39","author":"S Isami","year":"1996","unstructured":"Isami S, Kishikawa H, Araki E, Uehara M, Kaneko K, Shirotani T, et al. Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that Bradykinin stimulates the insulin signalling pathway. Diabetologia. 1996;39:412\u201320. https:\/\/doi.org\/10.1007\/BF00400672.","journal-title":"Diabetologia"},{"key":"2147_CR62","doi-asserted-by":"publisher","first-page":"R332","DOI":"10.1152\/ajpregu.1999.277.1.R332","volume":"277","author":"EJ Henriksen","year":"1999","unstructured":"Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ. ACE Inhibition and glucose transport in insulinresistant muscle: roles of Bradykinin and nitric oxide. Am J Physiol-Regul Integr Comp Physiol. 1999;277:R332\u20136. https:\/\/doi.org\/10.1152\/ajpregu.1999.277.1.R332.","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"key":"2147_CR63","doi-asserted-by":"publisher","first-page":"e2303259","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, et al. Nitric oxide: physiological Functions, Delivery, and biomedical applications. Adv Sci Weinh Baden-Wurtt Ger. 2023;10:e2303259. https:\/\/doi.org\/10.1002\/advs.202303259.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2147_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.celrep.2016.12.028","volume":"18","author":"A Sanyal","year":"2017","unstructured":"Sanyal A, Naumann J, Hoffmann LS, Chabowska-Kita A, Ehrlund A, Schlitzer A, et al. Interplay between Obesity-Induced inflammation and cGMP signaling in white adipose tissue. Cell Rep. 2017;18:225\u201336. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.028.","journal-title":"Cell Rep"},{"key":"2147_CR65","doi-asserted-by":"publisher","first-page":"2303259","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, et al. Nitric oxide: physiological Functions, Delivery, and biomedical applications. Adv Sci. 2023;10:2303259. https:\/\/doi.org\/10.1002\/advs.202303259.","journal-title":"Adv Sci"},{"key":"2147_CR66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000505343","volume":"13","author":"Y Lu","year":"2020","unstructured":"Lu Y, Ma J, Zhao J, Song Z, Zhou C, Liu X, et al. The role of MKP-5 in Adipocyte-Macrophage interactions during obesity. Obes Facts. 2020;13:86\u2013101. https:\/\/doi.org\/10.1159\/000505343.","journal-title":"Obes Facts"},{"issue":"Suppl 1","key":"2147_CR67","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.2337\/diab.45.1.s66","volume":"45","author":"K Rett","year":"1996","unstructured":"Rett K, Wicklmayr M, Dietze GJ, H\u00e4ring HU. Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by Bradykinin. Diabetes. 1996;45(Suppl 1):S66\u201369. https:\/\/doi.org\/10.2337\/diab.45.1.s66.","journal-title":"Diabetes"},{"key":"2147_CR68","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor Substrate-1 and phosphorylation of Ser307. J Biol Chem. 2000;275:9047\u201354. https:\/\/doi.org\/10.1074\/jbc.275.12.9047.","journal-title":"J Biol Chem"},{"key":"2147_CR69","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/jbc.M101521200","volume":"277","author":"V Aguirre","year":"2002","unstructured":"Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor Substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem. 2002;277:1531\u20137. https:\/\/doi.org\/10.1074\/jbc.M101521200.","journal-title":"J Biol Chem"},{"key":"2147_CR70","first-page":"BR109","volume":"10","author":"M Gibas","year":"2004","unstructured":"Gibas M, Torli\u0144ska T, Madry E, Ma\u0107kowlak P. Bradykinin-induced alterations of insulin-receptor interaction in rat adipose tissue under normo- and hypothermic conditions. Med Sci Monit Int Med J Exp Clin Res. 2004;10:BR109\u2013114.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"2147_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0140-6736(90)90538-G","volume":"335","author":"W Hartl","year":"1990","unstructured":"Hartl W. Effect of low-dose Bradykinin on glucose metabolism and nitrogen balance in surgical patients. Lancet. 1990;335:69\u201371. https:\/\/doi.org\/10.1016\/0140-6736(90)90538-G.","journal-title":"Lancet"},{"key":"2147_CR72","doi-asserted-by":"publisher","unstructured":"Yang C, Hsu WH. Stimulatory effect of Bradykinin on insulin release from the perfused rat pancreas. Am J Physiol. 1995;268. https:\/\/doi.org\/10.1152\/ajpendo.1995.268.5.E1027. :E1027-1030.","DOI":"10.1152\/ajpendo.1995.268.5.E1027"},{"key":"2147_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1006\/bbrc.1996.0638","volume":"221","author":"Y Saito","year":"1996","unstructured":"Saito Y, Kato M, Kubohara Y, Kobayashi I, Tatemoto K. Bradykinin increases intracellular free Ca2\u2009+\u2009concentration and promotes insulin secretion in the clonal beta-cell line, HIT-T15. Biochem Biophys Res Commun. 1996;221:577\u201380. https:\/\/doi.org\/10.1006\/bbrc.1996.0638.","journal-title":"Biochem Biophys Res Commun"},{"key":"2147_CR74","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1152\/ajpregu.1998.275.1.R40","volume":"275","author":"EJ Henriksen","year":"1998","unstructured":"Henriksen EJ, Jacob S, Fogt DL, Dietze GJ. Effect of chronic Bradykinin administration on insulin action in an animal model of insulin resistance. Am J Physiol-Regul Integr Comp Physiol. 1998;275:R40\u20135. https:\/\/doi.org\/10.1152\/ajpregu.1998.275.1.R40.","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"key":"2147_CR75","doi-asserted-by":"publisher","first-page":"1592683","DOI":"10.3389\/fendo.2025.1592683","volume":"16","author":"D Bou Matar","year":"2025","unstructured":"Bou Matar D, Zhra M, Nassar WK, Altemyatt H, Naureen A, Abotouk N, et al. Adipose tissue dysfunction disrupts metabolic homeostasis: mechanisms linking fat dysregulation to disease. Front Endocrinol. 2025;16:1592683. https:\/\/doi.org\/10.3389\/fendo.2025.1592683.","journal-title":"Front Endocrinol"},{"key":"2147_CR76","doi-asserted-by":"publisher","first-page":"e0267845","DOI":"10.1371\/journal.pone.0267845","volume":"17","author":"PE Correia","year":"2022","unstructured":"Correia PE, Gomes CB, Bandeira VA, Marten T, Natividade GR, Merello P, et al. Kinin B1 receptor deficiency protects mice fed by cafeteria diet from abnormal glucose homeostasis. PLoS ONE. 2022;17:e0267845. https:\/\/doi.org\/10.1371\/journal.pone.0267845.","journal-title":"PLoS ONE"},{"key":"2147_CR77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1463-1326.2011.01521.x","volume":"14","author":"JP Dias","year":"2012","unstructured":"Dias JP, Couture R. Blockade of Kinin B1 receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance. Diabetes Obes Metab. 2012;14:244\u201353. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01521.x.","journal-title":"Diabetes Obes Metab"},{"key":"2147_CR78","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/db18-1150","volume":"68","author":"VM Sales","year":"2019","unstructured":"Sales VM, Gon\u00e7alves-Zillo T, Castoldi A, Burgos M, Branquinho J, Batista C, et al. Kinin B1 receptor acts in adipose tissue to control fat distribution in a Cell-Nonautonomous manner. Diabetes. 2019;68:1614\u201323. https:\/\/doi.org\/10.2337\/db18-1150.","journal-title":"Diabetes"},{"key":"2147_CR79","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.molmet.2024.102078","volume":"91","author":"R Asgari","year":"2025","unstructured":"Asgari R, Caceres-Valdiviezo M, Wu S, Hamel L, Humber BE, Agarwal SM, et al. Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system. Mol Metab. 2025;91:102078. https:\/\/doi.org\/10.1016\/j.molmet.2024.102078.","journal-title":"Mol Metab"},{"key":"2147_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","volume":"23","author":"C Pic\u00f3","year":"2022","unstructured":"Pic\u00f3 C, Palou M, Pomar CA, Rodr\u00edguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23:13\u201330. https:\/\/doi.org\/10.1007\/s11154-021-09687-5.","journal-title":"Rev Endocr Metab Disord"},{"key":"2147_CR81","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00109-013-1004-6","volume":"91","author":"RG Fonseca","year":"2013","unstructured":"Fonseca RG, Sales VM, Ropelle E, Barros CC, Oyama L, Ihara SSI, et al. Lack of Kinin B1 receptor potentiates leptin action in the liver. J Mol Med. 2013;91:851\u201360. https:\/\/doi.org\/10.1007\/s00109-013-1004-6.","journal-title":"J Mol Med"},{"key":"2147_CR82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2147\/DMSO.S87635","volume":"8","author":"RL Morais","year":"2015","unstructured":"Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, et al. Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice. Diabetes Metab Syndr Obes Targets Ther. 2015;8:399\u2013407. https:\/\/doi.org\/10.2147\/DMSO.S87635.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"2147_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.regpep.2006.11.018","volume":"138","author":"KC Abe","year":"2007","unstructured":"Abe KC, Da Silva Mori MA, Pesquero JB. Leptin deficiency leads to the regulation of Kinin receptors expression in mice. Regul Pept. 2007;138:56\u20138. https:\/\/doi.org\/10.1016\/j.regpep.2006.11.018.","journal-title":"Regul Pept"},{"key":"2147_CR84","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.intimp.2007.07.025","volume":"8","author":"MA Mori","year":"2008","unstructured":"Mori MA, Ara\u00fajo RC, Pesquero JB. Kinin B1 receptor stimulation modulates leptin homeostasis. Evidence for an insulin-dependent mechanism. Int Immunopharmacol. 2008;8:242\u20136. https:\/\/doi.org\/10.1016\/j.intimp.2007.07.025.","journal-title":"Int Immunopharmacol"},{"key":"2147_CR85","doi-asserted-by":"publisher","first-page":"e40573","DOI":"10.1371\/journal.pone.0040573","volume":"7","author":"CC Barros","year":"2012","unstructured":"Barros CC, Haro A, Russo FJVP, Schadock I, Almeida SS, Ribeiro RA, et al. Altered glucose homeostasis and hepatic function in obese mice deficient for both Kinin receptor genes. PLoS ONE. 2012;7:e40573. https:\/\/doi.org\/10.1371\/journal.pone.0040573.","journal-title":"PLoS ONE"},{"key":"2147_CR86","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/labinvest.2012.105","volume":"92","author":"CC Barros","year":"2012","unstructured":"Barros CC, Haro A, Russo FJ, Schadock I, Almeida SS, Reis FC, et al. Bradykinin inhibits hepatic gluconeogenesis in obese mice. Lab Invest. 2012;92:1419\u201327. https:\/\/doi.org\/10.1038\/labinvest.2012.105.","journal-title":"Lab Invest"},{"key":"2147_CR87","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/antiox12071449","volume":"12","author":"S Cinti","year":"2023","unstructured":"Cinti S. Obese adipocytes have altered redox homeostasis with metabolic consequences. Antioxidants. 2023;12:1449. https:\/\/doi.org\/10.3390\/antiox12071449.","journal-title":"Antioxidants"},{"key":"2147_CR88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu H, Wang S, Wang J, Guo X, Song Y, Fu K, et al. Energy metabolism in health and diseases. Signal Transduct Target Ther. 2025;10:69. https:\/\/doi.org\/10.1038\/s41392-025-02141-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2147_CR89","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2007.12.003","volume":"200","author":"PF Mount","year":"2008","unstructured":"Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, Kemp BE, et al. Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis. 2008;200:28\u201336. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.12.003.","journal-title":"Atherosclerosis"},{"key":"2147_CR90","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","volume":"49","author":"T Inoguchi","year":"2000","unstructured":"Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C\u2013dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939\u201345. https:\/\/doi.org\/10.2337\/diabetes.49.11.1939.","journal-title":"Diabetes"},{"key":"2147_CR91","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MNH.0b013e32834d54b1","volume":"21","author":"Y Kayashima","year":"2012","unstructured":"Kayashima Y, Smithies O, Kakoki M. The kallikrein\u2013kinin system and oxidative stress. Curr Opin Nephrol Hypertens. 2012;21:92\u20136. https:\/\/doi.org\/10.1097\/MNH.0b013e32834d54b1.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2147_CR92","doi-asserted-by":"publisher","first-page":"e0206443","DOI":"10.1371\/journal.pone.0206443","volume":"13","author":"A Niewiarowska-Sendo","year":"2018","unstructured":"Niewiarowska-Sendo A, Kozik A, Guevara-Lora I. Influence of Bradykinin B2 receptor and dopamine D2 receptor on the oxidative stress, inflammatory response, and apoptotic process in human endothelial cells. PLoS ONE. 2018;13:e0206443. https:\/\/doi.org\/10.1371\/journal.pone.0206443.","journal-title":"PLoS ONE"},{"key":"2147_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/35024095","volume":"407","author":"S AbdAlla","year":"2000","unstructured":"AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 2000;407:94\u20138. https:\/\/doi.org\/10.1038\/35024095.","journal-title":"Nature"},{"key":"2147_CR94","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms25021310","volume":"25","author":"E Szczepanska-Sadowska","year":"2024","unstructured":"Szczepanska-Sadowska E. Interplay of angiotensin Peptides, Vasopressin, and insulin in the heart: experimental and clinical evidence of altered interactions in obesity and diabetes mellitus. Int J Mol Sci. 2024;25:1310. https:\/\/doi.org\/10.3390\/ijms25021310.","journal-title":"Int J Mol Sci"},{"key":"2147_CR95","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000556","author":"AE Midaoui","year":"2015","unstructured":"Midaoui AE. Effects of Alpha-Lipoic acid on oxidative stress and Kinin receptor expression in obese Zucker diabetic fatty rats. J Diabetes Metab [Internet]. 2015. https:\/\/doi.org\/10.4172\/2155-6156.1000556. [cited 2025 Oct 12];06.","journal-title":"J Diabetes Metab [Internet]"},{"key":"2147_CR96","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ijpo.270","volume":"10","author":"VS Farook","year":"2015","unstructured":"Farook VS, Reddivari L, Chittoor G, Puppala S, Arya R, Fowler SP, et al. Metabolites as novel biomarkers for childhood obesity-related traits in M exican\u2013 A Merican children. Pediatr Obes. 2015;10:320\u20137. https:\/\/doi.org\/10.1111\/ijpo.270.","journal-title":"Pediatr Obes"},{"key":"2147_CR97","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41440-021-00618-0","volume":"44","author":"FB Fernandes","year":"2021","unstructured":"Fernandes FB, Fernandes AB, Febba ACS, Leite APO, Leite CA, Vitalle MSS, et al. Association of Ang-(1\u20137) and des-Arg9BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents. Hypertens Res. 2021;44:969\u201377. https:\/\/doi.org\/10.1038\/s41440-021-00618-0.","journal-title":"Hypertens Res"},{"key":"2147_CR98","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00018-017-2658-y","volume":"75","author":"K Zieger","year":"2018","unstructured":"Zieger K, Weiner J, Kunath A, Gericke M, Krause K, Kern M, et al. Ablation of Kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo. Cell Mol Life Sci. 2018;75:727\u201342. https:\/\/doi.org\/10.1007\/s00018-017-2658-y.","journal-title":"Cell Mol Life Sci"},{"key":"2147_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/biomedicines9020131","volume":"9","author":"A Kunath","year":"2021","unstructured":"Kunath A, Weiner J, Krause K, Rehders M, Pejkovska A, Gericke M, et al. Role of Kallikrein 7 in body weight and fat mass regulation. Biomedicines. 2021;9:131. https:\/\/doi.org\/10.3390\/biomedicines9020131.","journal-title":"Biomedicines"},{"key":"2147_CR100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/psc.2621","volume":"20","author":"JT Heiker","year":"2014","unstructured":"Heiker JT. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation. J Pept Sci Off Publ Eur Pept Soc. 2014;20:299\u2013306. https:\/\/doi.org\/10.1002\/psc.2621.","journal-title":"J Pept Sci Off Publ Eur Pept Soc"},{"key":"2147_CR101","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00018-013-1258-8","volume":"70","author":"JT Heiker","year":"2013","unstructured":"Heiker JT, Kl\u00f6ting N, Kovacs P, Kuettner EB, Str\u00e4ter N, Schultz S, et al. Vaspin inhibits Kallikrein 7 by Serpin mechanism. Cell Mol Life Sci. 2013;70:2569\u201383. https:\/\/doi.org\/10.1007\/s00018-013-1258-8.","journal-title":"Cell Mol Life Sci"},{"key":"2147_CR102","doi-asserted-by":"publisher","first-page":"17762","DOI":"10.1074\/jbc.M115.643551","volume":"290","author":"Y Yu","year":"2015","unstructured":"Yu Y, Prassas I, Dimitromanolakis A, Diamandis EP. Novel biological substrates of human Kallikrein 7 identified through degradomics. J Biol Chem. 2015;290:17762\u201375. https:\/\/doi.org\/10.1074\/jbc.M115.643551.","journal-title":"J Biol Chem"},{"key":"2147_CR103","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1016\/j.bmc.2018.05.044","volume":"26","author":"H Murafuji","year":"2018","unstructured":"Murafuji H, Sugawara H, Goto M, Oyama Y, Sakai H, Imajo S, et al. Structure-based drug design to overcome species differences in Kallikrein 7 Inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones. Bioorg Med Chem. 2018;26:3639\u201353. https:\/\/doi.org\/10.1016\/j.bmc.2018.05.044.","journal-title":"Bioorg Med Chem"},{"key":"2147_CR104","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/ijms22083850","volume":"22","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte DJ, Zepeda-Garc\u00eda O, Dom\u00ednguez-P\u00e9rez M, Gonz\u00e1lez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22:3850. https:\/\/doi.org\/10.3390\/ijms22083850.","journal-title":"Int J Mol Sci"},{"key":"2147_CR105","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.metabol.2012.10.012","volume":"62","author":"H Zhu","year":"2013","unstructured":"Zhu H, Chao J, Kotak I, Guo D, Parikh SJ, Bhagatwala J, et al. Plasma Kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents. Metabolism. 2013;62:642\u20136. https:\/\/doi.org\/10.1016\/j.metabol.2012.10.012.","journal-title":"Metabolism"},{"key":"2147_CR106","doi-asserted-by":"publisher","first-page":"e1012552","DOI":"10.1371\/journal.pcbi.1012552","volume":"20","author":"A Rezvani-Sharif","year":"2024","unstructured":"Rezvani-Sharif A, Lioe H, Dower SK, Pelzing M, Panousis C, Harvie DJE, et al. A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors. PLoS Comput Biol. 2024;20:e1012552. https:\/\/doi.org\/10.1371\/journal.pcbi.1012552.","journal-title":"PLoS Comput Biol"},{"key":"2147_CR107","doi-asserted-by":"publisher","unstructured":"Kaplan AP, Joseph K. Pathogenic Mechanisms of Bradykinin Mediated Diseases. Adv Immunol [Internet]. Elsevier; 2014 [cited 2025 Oct 11]. pp. 41\u201389. https:\/\/doi.org\/10.1016\/B978-0-12-800100-4.00002-7","DOI":"10.1016\/B978-0-12-800100-4.00002-7"},{"key":"2147_CR108","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","volume":"27","author":"SK Ahmed","year":"2025","unstructured":"Ahmed SK, Mohammed RA. Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions. Metab Open. 2025;27:100375. https:\/\/doi.org\/10.1016\/j.metop.2025.100375.","journal-title":"Metab Open"},{"key":"2147_CR109","doi-asserted-by":"publisher","first-page":"e2521170","DOI":"10.1001\/jamanetworkopen.2025.21170","volume":"8","author":"E M\u00fcnte","year":"2025","unstructured":"M\u00fcnte E, Zhang X, Khurana A, Hartmann P. Prevalence of extremely severe obesity and metabolic dysfunction among US children and adolescents. JAMA Netw Open. 2025;8:e2521170. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.21170.","journal-title":"JAMA Netw Open"},{"key":"2147_CR110","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MCA.0000000000000604","volume":"29","author":"ME Marketou","year":"2018","unstructured":"Marketou ME, Kochiadakis G, Kontaraki J, Zacharis E, Kanoupakis E, Kallergis E, et al. Bradykinin receptors gene expression in white adipose tissue in nondiabetic patients with coronary artery disease. Coron Artery Dis. 2018;29:329\u201335. https:\/\/doi.org\/10.1097\/MCA.0000000000000604.","journal-title":"Coron Artery Dis"},{"key":"2147_CR111","doi-asserted-by":"publisher","first-page":"e2535004","DOI":"10.1001\/jamanetworkopen.2025.35004","volume":"8","author":"I Sequ\u00ed-Dom\u00ednguez","year":"2025","unstructured":"Sequ\u00ed-Dom\u00ednguez I, S\u00e1nchez-L\u00f3pez M, Garrido-Miguel M, Solera-Mart\u00ednez M, D\u00edaz-Go\u00f1i V, de Arenas-Arroyo SN, et al. Body composition and cardiometabolic risk in children. JAMA Netw Open. 2025;8:e2535004. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.35004.","journal-title":"JAMA Netw Open"},{"key":"2147_CR112","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1186\/s12889-025-24757-y","volume":"25","author":"H Yan","year":"2025","unstructured":"Yan H, Xu H, Chen R, Chen D, Li C. Effects of aerobic exercise on body composition in children and adolescents with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health. 2025;25:3321. https:\/\/doi.org\/10.1186\/s12889-025-24757-y.","journal-title":"BMC Public Health"},{"key":"2147_CR113","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Banerji A, Bracho F, Malbr\u00e1n A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363:532\u201341. https:\/\/doi.org\/10.1056\/NEJMoa0906393.","journal-title":"N Engl J Med"},{"key":"2147_CR114","doi-asserted-by":"publisher","first-page":"e107213","DOI":"10.1371\/journal.pone.0107213","volume":"9","author":"L Maneva-Radicheva","year":"2014","unstructured":"Maneva-Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with Recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213. https:\/\/doi.org\/10.1371\/journal.pone.0107213.","journal-title":"PLoS ONE"},{"key":"2147_CR115","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-med-043021-014919","volume":"74","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kushner RF. New frontiers in obesity treatment: GLP-1 and nascent Nutrient-Stimulated Hormone-Based therapeutics. Annu Rev Med. 2023;74:125\u201339. https:\/\/doi.org\/10.1146\/annurev-med-043021-014919.","journal-title":"Annu Rev Med"},{"key":"2147_CR116","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/cpdd.1534","volume":"14","author":"M Giuffre","year":"2025","unstructured":"Giuffre M, Lista AD, Paulson N, Masuoka L. A phase 1\u00a0C, open Label, single ascending dose study to evaluate the Safety, Tolerability, and pharmacokinetics of DM199 administered intravenously with a Polyvinyl chloride bag in adult healthy subjects and adults recently taking Angiotensin-Converting enzyme inhibitors. Clin Pharmacol Drug Dev. 2025;14:452\u201360. https:\/\/doi.org\/10.1002\/cpdd.1534.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2147_CR117","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jaip.2025.06.018","volume":"13","author":"MA Riedl","year":"2025","unstructured":"Riedl MA, Bernstein JA, Jacobs JS, Craig T, Banerji A, Perego F, et al. Donidalorsen treatment of hereditary angioedema in patients previously on Long-Term prophylaxis. J Allergy Clin Immunol Pract. 2025;13:2381\u2013e23893. https:\/\/doi.org\/10.1016\/j.jaip.2025.06.018.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2147_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2025.2573368","author":"AZ Al Meslamani","year":"2025","unstructured":"Al Meslamani AZ. Before you start: Understanding SGLT2 inhibitors for anti-obesity treatment. Expert Opin Drug Saf. 2025. https:\/\/doi.org\/10.1080\/14740338.2025.2573368.","journal-title":"Expert Opin Drug Saf"},{"key":"2147_CR119","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ndt\/gfae227","volume":"40","author":"A Bosi","year":"2025","unstructured":"Bosi A, Xu Y, Faucon A-L, Huang T, Evans M, Shin J-I, et al. Hyperkalemia and maintenance of renin\u2013angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors. Nephrol Dial Transpl. 2025;40:956\u201366. https:\/\/doi.org\/10.1093\/ndt\/gfae227.","journal-title":"Nephrol Dial Transpl"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02147-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:54:26Z","timestamp":1767200066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02147-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02147-9","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"177"}}